Milliman Funds Trust. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| TREASURY BILLBond | 25.92% | $257.68K | 258,200 |
| BondBloxx Bloomberg Five Year | 11.49% | $114.25K | 2,347 |
| State Street SPDR Portfolio S& | 8.80% | $87.53K | 996 |
| BondBloxx Bloomberg Six Month | 4.54% | $45.12K | 897 |
| Eli Lilly & CoLLY | 4.34% | $43.18K | 36 |
| UnitedHealth Group IncUNH | 3.76% | $37.41K | 90 |
| Johnson & JohnsonJNJ | 2.66% | $26.41K | 104 |
| Thermo Fisher Scientific IncTMO | 2.62% | $26.07K | 52 |
| Abbott LaboratoriesABT | 2.18% | $21.69K | 239 |
| SPDR Gold SharesDerivative | 2.13% | $21.13K | 8 |
| Intuitive Surgical IncISRG | 2.00% | $19.88K | 50 |
| Danaher CorpDHR | 1.88% | $18.67K | 98 |
| Stryker CorpSYK | 1.68% | $16.69K | 53 |
| Merck & Co IncMRK | 1.56% | $15.55K | 121 |
| Medtronic PLC | 1.40% | $13.92K | 178 |
| CVS Health CorpCVS | 1.29% | $12.83K | 124 |
| AbbVie IncABBV | 1.11% | $11.07K | 44 |
| Boston Scientific CorpBSX | 0.92% | $9.18K | 215 |
| McKesson CorpMCK | 0.91% | $9.07K | 12 |
| HCA Healthcare IncHCA | 0.90% | $8.97K | 23 |
| Elevance Health IncELV | 0.86% | $8.51K | 22 |
| Bristol-Myers Squibb CoBMY | 0.85% | $8.41K | 146 |
| Cigna Group/TheCI | 0.75% | $7.44K | 27 |
| Edwards Lifesciences CorpEW | 0.72% | $7.15K | 79 |
| Becton Dickinson & CoBDX | 0.59% | $5.90K | 39 |
| IDEXX Laboratories IncIDXX | 0.58% | $5.79K | 11 |
| Cencora IncCOR | 0.57% | $5.66K | 20 |
| Cardinal Health IncCAH | 0.55% | $5.46K | 23 |
| Agilent Technologies IncA | 0.53% | $5.31K | 40 |
| Humana IncHUM | 0.52% | $5.16K | 13 |
| Natera IncNTRA | 0.52% | $5.16K | 19 |
| United Therapeutics CorpUTHR | 0.49% | $4.88K | 9 |
| Waters CorpWAT | 0.49% | $4.88K | 13 |
| Medline IncMDLN | 0.49% | $4.85K | 123 |
| IQVIA Holdings IncIQV | 0.47% | $4.64K | 24 |
| Madrigal Pharmaceuticals IncMDGL | 0.43% | $4.30K | 8 |
| Veeva Systems IncVEEV | 0.43% | $4.26K | 24 |
| GE HealthCare Technologies IncGEHC | 0.42% | $4.22K | 66 |
| Revolution Medicines IncRVMD | 0.41% | $4.12K | 22 |
| ResMed IncRMD | 0.39% | $3.90K | 20 |
| Illumina IncILMN | 0.39% | $3.87K | 22 |
| Dexcom IncDXCM | 0.39% | $3.84K | 57 |
| Mettler-Toledo International IMTD | 0.39% | $3.83K | 3 |
| Moderna IncMRNA | 0.38% | $3.78K | 54 |
| West Pharmaceutical Services IWST | 0.36% | $3.59K | 10 |
| Quest Diagnostics IncDGX | 0.34% | $3.39K | 16 |
| Labcorp Holdings IncLH | 0.34% | $3.36K | 12 |
| Amgen IncAMGN | 0.33% | $3.26K | 9 |
| Centene CorpCNC | 0.32% | $3.15K | 49 |
| Neurocrine Biosciences IncNBIX | 0.31% | $3.03K | 18 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.